SWORD

Surveillance of Work-Related and Occupational Respiratory Disease
Survival with ORal D-sotalol. A trial that evaluated the effect of sotalol—a non-selective beta blocker and potassium channel blocker (a class III anti-arrhythmic)—therapy on the morbidity and mortality in patients with CHF
Conclusion Study stopped early when sotalol was linked to excess mortality .

SWORD

Cardiology A trial–Survival With Oral d-Sotalol–that evaluated the efficacy of d-sotalol therapy on the M&M in Pts with CHF. See Heart failure, d-Sotalol.